GMAB logo

Genmab A/S (GMAB) Company Overview

Profile

Full Name:

Genmab A/S

Sector:

Healthcare

Industry:

Biotechnology

Country:

Denmark

IPO:

June 1, 2009

Indexes:

Not included

Website:

http://www.genmab.com

Description:

Genmab A/S is a biotechnology company focused on developing innovative antibody therapies for cancer treatment. They create and commercialize new medicines to improve patient outcomes, collaborating with other companies to advance their research and bring new treatments to market.

Key Details

Price

$23.85

Market Cap

$15.16 B(Large cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$3.12 B(+30.58% YoY)

Annual EPS

$1.76(+83.70% YoY)

PE Ratio

13.62

Annual ROE

23.20%

Annual Debt To Equity

0.00

Beta

0.35

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 12, 2025

Recent annual earnings:

Feb 12, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 1, 2018

Analyst ratings

Recent major analysts updates

Feb 13, 25 Leerink Partners
Outperform
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 8, 25 HC Wainwright & Co.
Buy
Nov 8, 24 BMO Capital
Outperform
Oct 16, 24 HC Wainwright & Co.
Buy
Sep 20, 24 HC Wainwright & Co.
Buy
Sep 16, 24 HC Wainwright & Co.
Buy
Sep 13, 24 HC Wainwright & Co.
Buy
Sep 11, 24 Morgan Stanley
Equal-Weight

Screeners with GMAB included

Best performing stocks last 3 months
Best performing stocks last 5 years
Stocks above SMA 50
High revenue growth stocks
Stocks ready to break out
Healthcare sector
All stocks
High Altman Z score stocks
NASDAQ Listed Companies
Stocks with high RSI

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$23.85
GMAB price is $23.85

Price All-time High

$48.72
GMAB price is currently -51.05% below its historical high of $48.72

Price Analysts Target

-
GMAB price consensus analysts' forecast is unknown

Price Most Recent Change

+1.49%
GMAB price was up +1.49% on Mar 8, 2025

Price YTD Change

+14.94%
GMAB price is up +14.94% since January 1st

Price 3-Year Change

-25.4%
GMAB price is down -25.4% over the past 3 years

Market cap

Market Cap

$15.16 B
GMAB market capitalization is $15.16 billion

Market Cap 3-Year Change

-27.56%
GMAB market capitalization is down -27.56% over the past 3 years

Market Cap All-time High

$31.85 B
GMAB market capitalization is currently -52.42% below its historical high of $31.85 billion

Market Cap Sector Rank

94.81%
GMAB market capitalization is higher than 94.81% of companies in Healthcare sector

Technical

Beta

0.35
GMAB beta is 0.35

200-day SMA

$24.11
GMAB price is currently -1.06% below its 200-day simple moving average

14-day RSI

71.06
GMAB 14-day relative strength index is 71.06

30-day Relative Volume

0.45
GMAB 30-day relative volume is 0.45

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$3.12 B
GMAB annual revenue is $3.12 billion

Annual Revenue Analysts Estimate

$25.18 B
GMAB annual revenue is currently -87.60% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+30.58%
GMAB annual revenue is up +30.58% year-on-year

Annual Revenue Sector Rank

89.26%
GMAB annual revenue is higher than 89.26% of companies in Healthcare sector

Profit

Annual Gross Profit

$2.98 B
GMAB annual gross profit is $2.98 billion

Annual Gross Margin

95.42%
GMAB annual gross profit margin is 95.42%

Annual Operating Profit

$1.02 B
GMAB annual operating income is $1.02 billion

Annual Operating Margin

32.53%
GMAB annual operating profit margin is 32.53%

Annual Net Income

$1.14 B
GMAB annual net profit is $1.14 billion

Annual Net Margin

36.44%
GMAB annual net profit margin is 36.44%

EPS

Annual EPS

$1.76
GMAB annual earnings per share is $1.76

Annual EPS Analysts Estimate

$1.48
GMAB annual earnings per share is currently +18.65% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+83.7%
GMAB annual earnings per share is up +83.7% year-on-year

Annual EPS Sector Rank

91.04%
GMAB annual earnings per share is higher than 91.04% of companies in Healthcare sector

ROA & ROE

Annual ROA

19.57%
GMAB annual return on assets is 19.57%

Annual ROE

23.20%
GMAB annual return on equity is 23.20%

EBIT & EBITDA

Annual EBIT

$1.35 B
GMAB annual earnings before interest & taxes is $1.35 billion

Annual EBITDA

$1.41 B
GMAB annual EBITDA is $1.41 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

13.62
GMAB price to earnings ratio is 13.62

PE Ratio Sector Rank

20.69%
GMAB price to earnings ratio is higher than 20.69% of companies in Healthcare sector

PB Ratio

PB Ratio

2.96
GMAB price to book ratio is 2.96

PB Ratio Sector Rank

69.85%
GMAB price to book ratio is higher than 69.85% of companies in Healthcare sector

PS Ratio

PS Ratio

4.86
GMAB price to sales ratio is 4.86

PS Ratio Sector Rank

62.97%
GMAB price to sales ratio is higher than 62.97% of companies in Healthcare sector

Enterprise value

Enterprise Value

$13.92 B
GMAB enterprise value is $13.92 billion

Enterprise Value Sector Rank

93.36%
GMAB enterprise value is higher than 93.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.15
GMAB EV/EBITDA is 10.15

EV/EBITDA Sector Rank

81.96%
GMAB EV/EBITDA is higher than 81.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

5.25
GMAB annual current ratio is 5.25

Annual Quick Ratio

5.24
GMAB annual quick ratio is 5.24

Leverage

Annual Debt To Equity

0.00
GMAB annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

77.37
GMAB annual interest coverage ratio is 77.37

Risk & Stability

Piotroski F-Score

5
GMAB piotroski f-score is 5

Altman Z-Score

9.65
GMAB altman z-score is 9.65

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$6.39 B
GMAB annual total assets is $6.39 billion

Annual Non Current Assets

$2.51 B
GMAB annual long term assets is $2.51 billion

Annual Current Assets

$3.89 B
GMAB annual total current assets is $3.89 billion

Annual Cash & Cash Equivalents

$1.38 B
GMAB annual cash & cash equivalents is $1.38 billion

Equity

Annual Book Value

$5.12 B
GMAB annual book value is $5.12 billion

Annual Working Capital

$3.15 B
GMAB annual working capital is $3.15 billion

Liabilities

Annual Total Liabilities

$1.27 B
GMAB annual total liabilities is $1.27 billion

Annual Total Long Term Liabilities

$531.00 M
GMAB annual total long term liabilities is $531.00 million

Annual Current Liabilities

$740.56 M
GMAB annual total current liabilities is $740.56 million

Annual Accounts Payable

-
GMAB annual accounts payable value is unknown

Debt

Annual Total Debt

$143.56 M
GMAB annual total debt is $143.56 million

Annual Total Debt 1-Year Change

+25.58%
GMAB annual total debt is up +25.58% year-on-year

Annual Long Term Debt

$130.73 M
GMAB annual long term debt is $130.73 million

Annual Short Term Debt

$12.84 M
GMAB annual short term debt is $12.84 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$2.11 B
GMAB annual total expenses is $2.11 billion

Annual Operating Expenses

$1.96 B
GMAB annual total operating expenses is $1.96 billion

Annual Cost Of Goods Sold

$142.91 M
GMAB annual cost of goods sold is $142.91 million

Annual SGA

$549.89 M
GMAB annual SGA is $549.89 million

Annual D&A

$59.92 M
GMAB annual depreciation & amortization is $59.92 million

Annual Interest Expense

$17.41 M
GMAB annual interest expense is $17.41 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$1.13 B
GMAB annual cash flow from operations is $1.13 billion

Annual CFO 1-Year Change

+5.23%
GMAB annual cash flow from operations is up +5.23% year-on-year

Annual CFI

-$1.44 B
GMAB annual cash flow from investing activities is -$1.44 billion

Annual CFI 1-Year Change

-672.26%
GMAB annual cash flow from investing activities is down -672.26% year-on-year

Annual CFF

-$568.60 M
GMAB annual cash flow from financing activities is -$568.60 million

Annual CFF 1-Year Change

-546.27%
GMAB annual cash flow from financing activities is down -546.27% year-on-year

Free CashFlow

Annual FCF

$1.08 B
GMAB annual free cash flow is $1.08 billion

Annual FCF 1-Year Change

+6.54%
GMAB annual free cash flow is up +6.54% year-on-year

CAPEX

Annual CAPEX

$44.11 M
GMAB annual capital expenditures is $44.11 million

Annual CAPEX 1-Year Change

-19.2%
GMAB annual capital expenditures is down -19.2% year-on-year

Institutional Ownership

Similar stocks

ICLR logo
ICON Public Limited (ICLR)
RPRX logo
Royalty Pharma (RPRX)
HOLX logo
Hologic (HOLX)
UTHR logo
United Therapeutics (UTHR)
RVTY logo
Revvity (RVTY)
FMS logo
Fresenius Medical Care AG & Co KGaA (FMS)
SOLV logo
Solventum (SOLV)
ITCI logo
Intra-Cellular Therapies (ITCI)
MRNA logo
Moderna (MRNA)

FAQ

  • What is the ticker symbol for Genmab A/S?
  • Does Genmab A/S pay dividends?
  • What sector is Genmab A/S in?
  • What industry is Genmab A/S in?
  • What country is Genmab A/S based in?
  • When did Genmab A/S go public?
  • Is Genmab A/S in the S&P 500?
  • Is Genmab A/S in the NASDAQ 100?
  • Is Genmab A/S in the Dow Jones?
  • When was Genmab A/S's last earnings report?
  • When does Genmab A/S report earnings?

What is the ticker symbol for Genmab A/S?

The ticker symbol for Genmab A/S is NASDAQ:GMAB

Does Genmab A/S pay dividends?

No, Genmab A/S does not pay dividends

What sector is Genmab A/S in?

Genmab A/S is in the Healthcare sector

What industry is Genmab A/S in?

Genmab A/S is in the Biotechnology industry

What country is Genmab A/S based in?

Genmab A/S is headquartered in Denmark

When did Genmab A/S go public?

Genmab A/S's initial public offering (IPO) was on June 1, 2009

Is Genmab A/S in the S&P 500?

No, Genmab A/S is not included in the S&P 500 index

Is Genmab A/S in the NASDAQ 100?

No, Genmab A/S is not included in the NASDAQ 100 index

Is Genmab A/S in the Dow Jones?

No, Genmab A/S is not included in the Dow Jones index

When was Genmab A/S's last earnings report?

Genmab A/S's most recent earnings report was on Feb 12, 2025

When does Genmab A/S report earnings?

The next expected earnings date for Genmab A/S is May 8, 2025